Furthermore, this immunosuppressive effect could be significantly enhanced by pre-treating the DFSCs with interferon-gamma (IFN-γ), indicating that the cells’ therapeutic activity efficacy can be a future cell-based treatment for allergic diseases like asthma [185,186]. The gene discussed is IFNG; the disease is asthma.